<SEC-DOCUMENT>0000950170-22-013497-index.html : 20220729
<SEC-HEADER>0000950170-22-013497.hdr.sgml : 20220729
<ACCEPTANCE-DATETIME>20220729160045
ACCESSION NUMBER:		0000950170-22-013497
CONFORMED SUBMISSION TYPE:	NT 20-F
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220729
DATE AS OF CHANGE:		20220729
EFFECTIVENESS DATE:		20220729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Virax Biolabs Group Ltd
		CENTRAL INDEX KEY:			0001885827
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		NT 20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41440
		FILM NUMBER:		221120686

	BUSINESS ADDRESS:	
		STREET 1:		30 BROADWICK STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1F 8LX
		BUSINESS PHONE:		44 020 7788 7414

	MAIL ADDRESS:	
		STREET 1:		30 BROADWICK STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1F 8LX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Virax Biolabs (Cayman) Ltd
		DATE OF NAME CHANGE:	20210930
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 20-F
<SEQUENCE>1
<FILENAME>vrax_nt_20f.htm
<DESCRIPTION>NT 20-F
<TEXT>
Document 1 - file: vrax_nt_20f.htm

</DOCUMENT>
</SEC-DOCUMENT>